Division of Geriatric Medicine

Alexandra Papaioannou

M.D., M.Sc., F.R.C.P.(C), F.A.C.P.

Professor, Division of Geriatric Medicine, Department of Medicine

Chairholder, Eli Lilly Canada Chair in Osteoporosis

Associate Member, Centre for Evaluation of Medicines

 

Education and Professional Standing

Dr. Alexandra Papaioannou is a Professor in the Department of Medicine and a Geriatrician at Hamilton Health Sciences.  She is the past Director of the Division of Geriatric Medicine, McMaster University with joint appointment in the Division of Rheumatology.  Dr Papaioannou has received a CIHR Research Chair – Eli Lilly Osteoporosis and Fracture Prevention and was a prior Ontario Career Scientist.  She is an Associate Member in the Department of Clinical Epidemiology and Biostatistics and has completed Masters of Science (MSc), Health Research Methods at McMaster University.  Dr. Papaioannou is past Chair of the Scientific Advisory Council of Osteoporosis Canada (OC) and past Chair of the Board.  She is the project lead for the Ontario Osteoporosis Strategy for Fracture Prevention in Long-term Care, Co-Director of the Hamilton Canadian Multi-Centre Osteoporosis Study (CaMos) and is leading the Fracture Think Osteoporosis project, a chronic disease management program in Hamilton, Ontario.
Dr. Papaioannou is a member of the Scientific Advisors of the International Osteoporosis Foundation.

Selected Publications

  1. Papaioannou A, Kennedy CC, Ioannidis G, Brown JP, Pathak A, Hanley DA, Josse RJ, Sebaldt R, Olszynski WP, Tenenhouse A, Murray TM, Petrie A, Goldsmith CH, Adachi JD.  Determinants of health-related quality of life in women with vertebral fractures.  Osteoporosis Int, 2006;17(3):355-363.
  2. Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson H, Prior JC, Goltzman D. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Int Med. 2007; 167(2):188-194.
  3. Papaioannou A, Kennedy CC, Dolovich L, Lau E, Adachi JD.  Patient Adherence with   Osteoporosis Medications:  Problems, Consequences and Management Strategies.  Drugs Aging. 2007;24(1):37-55.
  4. Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, Johnstone D, Plumley N, Crowley C, Baldwin A, Doupe M, Katz A, Salach L, Adachi J.  Rationale, Methods, and Feasibility of the Canadian Quality Circles (CQC) Project: An Integrated Disease Management Process.  Can Fam Physician.  2007 Oct;53:1694-1700.
  5. Papaioannou A, Kennedy C, Ioannidis G, Gao Y, Sawka AM, Goltzman D, Tenenhouse A, Pickard L, Olszynski WP, Davison KS, Kaiser S, Josse RG, Kreiger N, Hanley DA, Prior JC, Brown JP, Anastassiades T, Adachi JD, CaMos Research Group.  The Osteoporosis Care Gap in Men with Fragility Fractures: The Canadian Multicentre Osteoporosis Study.  Osteoporos Int. 2007 19:581-587.
  6. Lau E, Papaioannou A, Dolovich L, Adachi J, Sawka AM, Burns S, Nair K, Pathak A. Patients’ adherence to osteoporosis therapy: Exploring the perceptions of postmenopausal women. Can Fam Physician. 2008 Mar;54(3):394-402.
  7. Verhovsek M, Motlagh B, Crowther MA, Kennedy C, Dolovich L, Campbell G, Wang L, Papaioannou A.  Quality of anticoagulation and use of warfarin-interacting medications in long-term care:  A chart review.  BMC Geriatr. 2008 Jul 3;8:13.
  8. Papaioannou A, Kennedy C, Freitag A, Ioannidis G, O’Neill J, Webber C, Pui M, Berthiaume Y, Rabin HR, Paterson N, Jeanneret A, Matouk E, Villeneuve J, Nixon M, Adachi JD.  Alendronate Once Weekly for the Prevention and Treatment of Osteoporosis in Canadian Adult Cystic Fibrosis Patients (CFOS Trial).  Chest 2008 Oct;134(4):794-800.
  9. Papaioannou A, Kennedy C, Freitag A, O’Neill J, Pui M, Ioannidis G, Webber C, Pathak A, Hansen S, Hennessey R, Adachi JD.  Longitudinal analysis of vertebral fracture and BMD in a Canadian cohort of adult cystic fibrosis patients.  BMC Musculoskelet Disord.  2008 Sep 19;9:125.
  10. Oliver D, Papaioannou A, Giangregorio L, Thabane L, Reizgys K, Foster G. A systematic review and meta-analysis of studies using the STRATIFY tool for prediction of falls in hospital patients: how well does it work?Age and Ageing.2008 Nov;37(6):621-7.
  11. Papaioannou A, Kennedy CC, Cranney A, Hawker G, Brown JP, Kaiser SM, Leslie WD, O’Brien CJM, Sawka AM, Khan A, Siminoski K, Tarulli G, Webster D, McGowan J, Adachi JD.  Risk factors for low BMD in healthy men age 50 years or older: a systematic review.  Osteoporosis Int. 2009; 20:507-518 DOI 10.1007/s00198-008-0720-1.
  12. Papaioannou A, Kennedy C, Ioannidis G, Sawka A, Hopman W, Pickard L, Brown JP, Josse RG, Kaiser S, Anastassiades T, Goltzman D, Papadimitropoulos M., Tenenhouse A, Prior JC, Olszynski WP, Adachi JD, for the CaMos Study Group.  The impact of incident fractures on health-related quality of life:  5 years of data from the Canadian Multicentre Osteoporosis Study.  Osteoporosis International (2009) 20:703–714.
  13. Giangregorio LM, Jantzi M, Papaioannou A, Hirdes J, Maxwell CJ, Poss JW. Osteoporosis management among residents living in long-term care. Osteoporosis Int. 2009 Sep;20(9):1471-8.
  14. Papaioannou A, Kennedy CC, Cranney A, Hawker G, Brown JP, Kaiser SM, Leslie WD, O’Brien CJM., Sawka AM, Khan A., Siminoski K, Tarulli G., Webster D., McGowan J, Adachi  JD.  Risk factors for low BMD in healthy men age 50 years or older: a systematic review.  Osteoporosis Int 2009 Apr;20(4):507-18.
  15. Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, Walsh A, Jiwa F, Adachi JD.  Family physicians’ personal and practice characteristics that are associated with improved utilization of bone mineral density testing and osteoporosis medication prescribing.  Population Health Manag. 2009 Jun;12(3):131-8.
  16. Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, Walsh A, Jiwa F, Adachi JD.  The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention:  the Canadian quality circle project (CQC).  BMC Med Educ. 2009 Aug 6;9:54.
  17. Ioannidis G, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pickard L, Kennedy CC, Prior JC, Olszynski WP, Davison KS, Goltzman D, Thabane L, Gafni A, Papadimitropoulos EA, Brown JP, Josse RG, Hanley DA, Adachi JD.  Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study.  CMAJ 2009. DOI:10.1503/cmaj.081720.
  18. Abid S, Papaioannou A.  Vertebral Compressions Fractures Among Older Adults. Geriatrics and Aging Jan/Feb 2009; 12(1): 10-20.
  19. Leslie WD, O’Donnell S, Jean S, Lagace C, Walsh P, Bancej C, Morin S, Hanley DA, Papaioannou A. for the Osteoporosis Surveillance Expert Working Group. Trends in Hip Fracture Rates in Canada. JAMA 2009 Aug 26;302(8):883-889.
  20. Giangregorio LM, Thabane L, deBeer J, Farrauto L, McCartney N, Adachi JD, Papaioannou A. Body weight- supported treadmill training for patients with hip fracture: a feasibility study. Arch Phys Med Rehabil 2009;90:2125-30.
  21. Jaglal SB, Hawker G, Cameron C, Canavan J, Beaton D, Bogoch E, Jain R, Papaioannou A; members of the Osteoporosis Research, Monitoring and Evaluation Working Group.  The Ontario Osteoporosis Strategy: implementation of a population-based osteoporosis action plan in Canada. Osteoporosis Int 2010 Jun;21(6):903-8
  22. Papaioannou A, Kennedy CC, Campbell G, Stroud J, Wang L, Dolovich L, Crowther MA and the Improving Prescribing in Long Term Care Investigators. A team-based approach to warfarin management in long term care: A feasibility study of the MEDeINR electronic decision support system. BMC Geriatr2010 Jun 10; 10:38